Viewing Study NCT06597656

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:24 PM
Ignite Modification Date: 2026-01-22 @ 3:25 PM
Study NCT ID: NCT06597656
Status: TERMINATED
Last Update Posted: 2025-09-04
First Post: 2024-09-12
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: A Gene Transfer Therapy to Evaluate the Safety and Efficacy of Delandistrogene Moxeparvovec (SRP-9001) Following Therapeutic Plasma Exchange (Plasmapheresis) in Participants With Duchenne Muscular Dystrophy (DMD) and Pre-existing Antibodies to AAVrh74
Sponsor: Sarepta Therapeutics, Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Duchenne Muscular Dystrophy View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Gene-Delivery View
None DMD View
None Ambulatory View
None Pediatric View
None Duchenne View
None Seropositive View
None Pre-existing antibodies View
None AAVrh74 antibody View
None Plasmapheresis View
None Titer View
None Seropositivity View